Keros updates corporate deck; no material facts discernible from truncated exhibit

Keros Therapeutics, Inc.

Keros Therapeutics furnished an updated corporate presentation for investor meetings under Item 7.01.
The attached Exhibit 99.1 text is incomplete in the filing, preventing extraction of specific updates.
No financial results, clinical milestones, or guidance changes can be confirmed from available text.
The filing is a routine practice and does not indicate any material new development.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.